|
|
Volumn 44, Issue 1, 2016, Pages 182-187
|
|
Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs
a
a
b
b
a
a
|
|
Author keywords
HPMC polymer; Nanoaggregates; Pulmonary drug delivery; Spray dried powders
|
|
Indexed keywords
ENCAPSULATION;
POWDERS;
SPRAY DRYING;
DRUG ENCAPSULATION EFFICIENCY;
HPMC POLYMERS;
NANOAGGREGATES;
PRECIPITATION TECHNIQUES;
PULMONARY DELIVERY;
PULMONARY DRUG DELIVERY;
SPRAY-DRIED POWDERS;
THERAPEUTIC DRUGS;
DRUG DOSAGE;
ISONIAZID;
NANOCARRIER;
RIFAMPICIN;
HYDROXYPROPYLMETHYLCELLULOSE;
NANOPARTICLE;
NOSE SPRAY;
POWDER;
TUBERCULOSTATIC AGENT;
AEROSOL;
ANGLE OF REPOSE;
ANIMAL EXPERIMENT;
AREA UNDER THE MOMENT CURVE;
ARTICLE;
DRUG BLOOD LEVEL;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG SYNTHESIS;
DRY POWDER INHALER;
FEMALE;
HYDROPHOBICITY;
IN VITRO STUDY;
IN VIVO STUDY;
INTRAPULMONARY DRUG ADMINISTRATION;
LUNG ALVEOLUS MACROPHAGE;
MALE;
MAXIMUM PLASMA CONCENTRATION;
MEAN RESIDENCE TIME;
MOISTURE;
NANOENCAPSULATION;
NONHUMAN;
PARTICLE SIZE;
PRECIPITATION;
RAT;
SPRAY DRYING;
SUSTAINED DRUG RELEASE;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ANIMAL;
CHEMISTRY;
DRUG DELIVERY SYSTEM;
DRUG EFFECTS;
DRUG FORMULATION;
DRUG RELEASE;
INHALATIONAL DRUG ADMINISTRATION;
LUNG;
METABOLISM;
POWDER;
PROCEDURES;
ULTRASTRUCTURE;
WISTAR RAT;
ADMINISTRATION, INHALATION;
ANIMALS;
ANTITUBERCULAR AGENTS;
DRUG COMPOUNDING;
DRUG DELIVERY SYSTEMS;
DRUG LIBERATION;
FEMALE;
HYPROMELLOSE DERIVATIVES;
ISONIAZID;
LUNG;
MALE;
NANOPARTICLES;
NASAL SPRAYS;
PARTICLE SIZE;
POWDERS;
RATS;
RATS, WISTAR;
RIFAMPIN;
|
|
EID: 84971635869
PISSN: 21691401
EISSN: 2169141X
Source Type: Journal
DOI: 10.3109/21691401.2014.930747 Document Type: Article |
|
Times cited : (32)
|
|
References (11)
|
